- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
- 9.
- 10.
- 11.
- 12.
Kong, C.H.T.; Rog-Zielinska, E.A.; Kohl, P.; et al. Solute movement in the t-tubule system of rabbit and mouse cardiomyocytes. Proc. Natl. Acad. Sci. USA 2018, 115, E7073–E7080.
- 13.
- 14.
- 15.
- 16.
- 17.
- 18.
- 19.
- 20.
- 21.
- 22.
Song, L.S.; Sobie, E.A.; McCulle, S.; et al. Orphaned ryanodine receptors in the failing heart. Proc. Natl. Acad. Sci. USA 2006, 103, 4305–4310.
- 23.
- 24.
- 25.
- 26.
- 27.
Tanaka, H.; Namekata, I.; Takeda, K.; et al. Unique excitation–contraction characteristics of mouse myocardium as revealed by SEA0400, a specific inhibitor of Na+–Ca2+ exchanger. Naunyn-Schmiedeberg’S Arch. Pharmacol. 2005, 371, 526–534.
https://link.springer.com/article/10.1007/s00210-005-1051-9.
- 28.
- 29.
- 30.
- 31.
- 32.
- 33.
- 34.
- 35.
- 36.
- 37.
- 38.
- 39.
- 40.
- 41.
- 42.
- 43.
- 44.
- 45.
- 46.
- 47.
Galbiati, F.; Engelman, J.A.; Volonte, D.; et al. Caveolin-3 Null Mice Show a Loss of Caveolae, Changes in the Microdomain Distribution of the Dystrophin-Glycoprotein Complex, and T-tubule Abnormalities. J. Biol. Chem. 2001, 276, 21425–21433.
https://www.jbc.org/article/S0021-9258(20)78712-0/fulltext.
- 48.
- 49.
- 50.
- 51.
- 52.
- 53.
- 54.
- 55.
- 56.
- 57.
Lawless, M.; Caldwell, J.L.; Radcliffe, E.J.; et al. Phosphodiesterase 5 inhibition improves contractile function and restores transverse tubule loss and catecholamine responsiveness in heart failure. Sci. Rep. 2019, 9, 6801.
https://www.nature.com/articles/s41598-019-42592-1.
- 58.
Muller, A.J.; Baker, J.F.; DuHadaway, J.B.; et al. Targeted Disruption of the Murine Bin1/Amphiphysin II Gene Does Not Disable Endocytosis but Results in Embryonic Cardiomyopathy with Aberrant Myofibril Formation. Mol. Cell. Biol. 2003, 23, 4295–4306.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC156129/.
- 59.
- 60.
- 61.
- 62.
- 63.
Hong, T.T.; Smyth, J.W.; Gao, D.; et al. BIN1 Localizes the L-Type Calcium Channel to Cardiac T-Tubules. PLoS Biol. 2010, 8, e1000312–2.
- 64.
- 65.
- 66.
Fugier, C.; Klein, A.F.; Hammer, C.; et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat. Med. 2011, 17, 720–725.
https://www.nature.com/articles/nm.2374.
- 67.
- 68.
Pieske, B.; Tschöpe, C.; De Boer, R.A.; et al. How to diagnose heart failure with preserved ejection fraction: The HFA–PEFF diagnostic algorithm: A consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. Heart J. 2019, 40, 3297–3317.
https://academic.oup.com/eurheartj/article/40/40/3297/5557740?login=false.
- 69.
- 70.
Maron, B.J.; Ferrans, V.J.; Roberts, W.C. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am. J. Pathol. 1975, 79, 387–434.
- 71.
Schaper, J.; Froede, R.; Hein, S.; et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991, 83, 504–514.
- 72.
- 73.
- 74.
Pinali, C.; Malik, N.J.; Davenport, B.; et al. Post-Myocardial Infarction T-tubules Form Enlarged Branched Structures with Dysregulation of Junctophilin-2 and Bridging Integrator 1 (BIN-1). J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 2017, 6, e004834.
- 75.
Seidel, T.; Navankasattusas, S.; Ahmad, A.; et al. Sheet-Like Remodeling of the Transverse Tubular System in Human Heart Failure Impairs Excitation-Contraction Coupling and Functional Recovery by Mechanical Unloading. Circulation 2017, 135, 1632–1645.
- 76.
Fiegle, D.J.; Schöber, M.; Dittrich, S.; et al. Severe T-System Remodeling in Pediatric Viral Myocarditis. Front. Cardiovasc. Med. 2021, 7, 624776.
- 77.
- 78.
- 79.
- 80.
- 81.
- 82.
Terracciano, C. Changes in sarcolemmal Ca entry and sarcoplasmic reticulum Ca content in ventricular myocytes from patients with end-stage heart failure following myocardial recovery after combined pharmacological and ventricular assist device therapy. Eur. Heart J. 2003, 24, 1329–1339.
https://academic.oup.com/eurheartj/article/24/14/1329/501780.
- 83.
Briston, S.J.; Caldwell, J.L.; Horn, M.A.; et al. Impaired β-adrenergic responsiveness accentuates dysfunctional excitation–contraction coupling in an ovine model of tachypacing-induced heart failure. J. Physiol. 2011, 589, 1367–1382.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082097/.
- 84.
- 85.
- 86.
Schobesberger, S.; Wright, P.T.; Poulet, C.; et al. β3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes. eLife 2020, 9, e52221.
https://elifesciences.org/articles/52221.
- 87.
- 88.
- 89.
Surdo, N.C.; Berrera, M.; Koschinski, A.; et al. FRET biosensor uncovers cAMP nano-domains at β-adrenergic targets that dictate precise tuning of cardiac contractility. Nat. Commun. 2017, 8, 15031.
https://www.nature.com/articles/ncomms15031.
- 90.
- 91.
- 92.
- 93.
- 94.
- 95.
Edwards, A.G.; Louch, W.E. Species-dependent mechanisms of cardiac arrhythmia: A cellular focus. Clin. Med. Insights Cardiol. 2017, 11, 1179546816686061.
- 96.
- 97.
- 98.
- 99.
- 100.
- 101.
- 102.
- 103.
- 104.
- 105.
- 106.
Lahiri, S.K.; Quick, A.P.; Samson-Couterie, B.; et al. Nuclear localization of a novel calpain-2 mediated junctophilin-2 C-terminal cleavage peptide promotes cardiomyocyte remodeling. Basic Res. Cardiol. 2020, 115, 1–13.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113426/.
- 107.
- 108.
Wang, S.; Zhou, Y.; Luo, Y.; et al. SERCA2a ameliorates cardiomyocyte T-tubule remodeling via the calpain/JPH2 pathway to improve cardiac function in myocardial ischemia/reperfusion mice. Sci. Rep. 2021, 11, 2037.
https://www.nature.com/articles/s41598-021-81570-4.
- 109.
- 110.
- 111.
- 112.
Hassel, D.; Dahme, T.; Erdmann, J.; et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat. Med. 2009, 15, 1281–1288.
https://www.nature.com/articles/nm.2037.
- 113.
- 114.
Haas, J.; Frese, K.S.; Peil, B.; et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur. Heart J. 2014, 36, 1123–1135.
- 115.
- 116.
- 117.
- 118.
- 119.
- 120.
- 121.
He, B.; Tang, R.; Weisleder, N.; et al. Enhancing Muscle Membrane Repair by Gene Delivery of MG53 Ameliorates Muscular Dystrophy and Heart Failure in δ-Sarcoglycan-deficient Hamsters. Mol. Ther. 2012, 20, 727–735.
- 122.
- 123.
- 124.
Nikolova, A.P.; Hitzeman, T.C.; Baum, R.; et al. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization. JAMA Cardiol. 2018, 3, 1206.
- 125.
- 126.
- 127.
Xie, Y.P.; Chen, B.; Sanders, P.; et al. Sildenafil Prevents and Reverses Transverse-Tubule Remodeling and Ca2+ Handling Dysfunction in Right Ventricle Failure Induced by Pulmonary Artery Hypertension. Hypertension 2012, 59, 355–362.
- 128.
Li, H.; Lichter, J.G.; Seidel, T.; et al. Cardiac Resynchronization Therapy Reduces Subcellular Heterogeneity of Ryanodine Receptors, T-Tubules, and Ca2+ Sparks Produced by Dyssynchronous Heart Failure. Circ. Heart Fail. 2015, 8, 1105–1114.
- 129.
- 130.
- 131.
- 132.